81 research outputs found
Frank H. Knight on the “Entrepreneur Function” in Modern Enterprise
This Article explores Knight’s theory of the entrepreneurial function in the modern enterprise in two contexts. The first is Berle and Means’s arguments, in which I offer a reconstruction of Knight that responds to the argument in The Modern Corporation regarding both the corporate separation of ownership and control, and the potential for industrial policy to promote the social interest. The second context I use to explore Knight’s understanding of entrepreneurship is his later arguments regarding the problem of intelligent control in a democratic society. From the 1930s to the end of his life in the early 1970s, Knight increasingly focused on the nature of a free, democratic society and the attendant problems for a social science that wishes to inform democratic action. While it is convenient to divide his life’s work into two parts—the first focused on economic theory (ending in the early 1940s) and the second on social philosophy—the two are connected by a conception of human and social action in the midst of uncertainty that runs from Risk, Uncertainty, and Profit to Knight’s last book, Intelligence and Democratic Action
Frank H. Knight on the “Entrepreneur Function” in Modern Enterprise
This Article explores Knight’s theory of the entrepreneurial function in the modern enterprise in two contexts. The first is Berle and Means’s arguments, in which I offer a reconstruction of Knight that responds to the argument in The Modern Corporation regarding both the corporate separation of ownership and control, and the potential for industrial policy to promote the social interest. The second context I use to explore Knight’s understanding of entrepreneurship is his later arguments regarding the problem of intelligent control in a democratic society. From the 1930s to the end of his life in the early 1970s, Knight increasingly focused on the nature of a free, democratic society and the attendant problems for a social science that wishes to inform democratic action. While it is convenient to divide his life’s work into two parts—the first focused on economic theory (ending in the early 1940s) and the second on social philosophy—the two are connected by a conception of human and social action in the midst of uncertainty that runs from Risk, Uncertainty, and Profit to Knight’s last book, Intelligence and Democratic Action
Climate drives the geography of marine consumption by changing predator communities
Este artículo contiene 7 páginas, 3 figuras, 1 tabla.The global distribution of primary production and consumption by
humans (fisheries) is well-documented, but we have no map linking
the central ecological process of consumption within food
webs to temperature and other ecological drivers. Using standardized
assays that span 105° of latitude on four continents, we show
that rates of bait consumption by generalist predators in shallow
marine ecosystems are tightly linked to both temperature and the
composition of consumer assemblages. Unexpectedly, rates of
consumption peaked at midlatitudes (25 to 35°) in both Northern
and Southern Hemispheres across both seagrass and unvegetated
sediment habitats. This pattern contrasts with terrestrial systems,
where biotic interactions reportedly weaken away from the equator,
but it parallels an emerging pattern of a subtropical peak in
marine biodiversity. The higher consumption at midlatitudes was
closely related to the type of consumers present, which explained
rates of consumption better than consumer density, biomass, species
diversity, or habitat. Indeed, the apparent effect of temperature
on consumption was mostly driven by temperature-associated turnover
in consumer community composition. Our findings reinforce
the key influence of climate warming on altered species composition
and highlight its implications for the functioning of Earth’s
ecosystems.We acknowledge funding from the Smithsonian
Institution and the Tula Foundation.Peer reviewe
Economic Analysis of Labor Markets and Labor Law: An Institutional/Industrial Relations Perspective
Fine-Mapping, Gene Expression and Splicing Analysis of the Disease Associated LRRK2 Locus
Association studies have identified several signals at the LRRK2 locus for Parkinson's disease (PD), Crohn's disease (CD) and leprosy. However, little is known about the molecular mechanisms mediating these effects. To further characterize this locus, we fine-mapped the risk association in 5,802 PD and 5,556 controls using a dense genotyping array (ImmunoChip). Using samples from 134 post-mortem control adult human brains (UK Human Brain Expression Consortium), where up to ten brain regions were available per individual, we studied the regional variation, splicing and regulation of LRRK2. We found convincing evidence for a common variant PD association located outside of the LRRK2 protein coding region (rs117762348, A>G, P = 2.56×10(-8), case/control MAF 0.083/0.074, odds ratio 0.86 for the minor allele with 95% confidence interval [0.80-0.91]). We show that mRNA expression levels are highest in cortical regions and lowest in cerebellum. We find an exon quantitative trait locus (QTL) in brain samples that localizes to exons 32-33 and investigate the molecular basis of this eQTL using RNA-Seq data in n = 8 brain samples. The genotype underlying this eQTL is in strong linkage disequilibrium with the CD associated non-synonymous SNP rs3761863 (M2397T). We found two additional QTLs in liver and monocyte samples but none of these explained the common variant PD association at rs117762348. Our results characterize the LRRK2 locus, and highlight the importance and difficulties of fine-mapping and integration of multiple datasets to delineate pathogenic variants and thus develop an understanding of disease mechanisms
Direct detection and quantitation of He@C60 by ultrahigh-resolution Fourier transform ion cyclotron resonance mass spectrometry
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection
Background
The mutational landscape of SARS-CoV-2 varies at the dominant viral genome sequence and minor genomic variant population. During the COVID-19 pandemic, an early substitution in the genome was the D614G change in the spike protein, associated with an increase in transmissibility. Genomes with D614G are accompanied by a P323L substitution in the viral polymerase (NSP12). However, P323L is not thought to be under strong selective pressure.
Results
Investigation of P323L/D614G substitutions in the population shows rapid emergence during the containment phase and early surge phase during the first wave. These substitutions emerge from minor genomic variants which become dominant viral genome sequence. This is investigated in vivo and in vitro using SARS-CoV-2 with P323 and D614 in the dominant genome sequence and L323 and G614 in the minor variant population. During infection, there is rapid selection of L323 into the dominant viral genome sequence but not G614. Reverse genetics is used to create two viruses (either P323 or L323) with the same genetic background. L323 shows greater abundance of viral RNA and proteins and a smaller plaque morphology than P323.
Conclusions
These data suggest that P323L is an important contribution in the emergence of variants with transmission advantages. Sequence analysis of viral populations suggests it may be possible to predict the emergence of a new variant based on tracking the frequency of minor variant genomes. The ability to predict an emerging variant of SARS-CoV-2 in the global landscape may aid in the evaluation of medical countermeasures and non-pharmaceutical interventions
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) : part two
Background
The immunological escape of tumors represents one of the main ob- stacles to the treatment of malignancies. The blockade of PD-1 or CTLA-4 receptors represented a milestone in the history of immunotherapy. However, immune checkpoint inhibitors seem to be effective in specific cohorts of patients. It has been proposed that their efficacy relies on the presence of an immunological response. Thus, we hypothesized that disruption of the PD-L1/PD-1 axis would synergize with our oncolytic vaccine platform PeptiCRAd.
Methods
We used murine B16OVA in vivo tumor models and flow cytometry analysis to investigate the immunological background.
Results
First, we found that high-burden B16OVA tumors were refractory to combination immunotherapy. However, with a more aggressive schedule, tumors with a lower burden were more susceptible to the combination of PeptiCRAd and PD-L1 blockade. The therapy signifi- cantly increased the median survival of mice (Fig. 7). Interestingly, the reduced growth of contralaterally injected B16F10 cells sug- gested the presence of a long lasting immunological memory also against non-targeted antigens. Concerning the functional state of tumor infiltrating lymphocytes (TILs), we found that all the immune therapies would enhance the percentage of activated (PD-1pos TIM- 3neg) T lymphocytes and reduce the amount of exhausted (PD-1pos TIM-3pos) cells compared to placebo. As expected, we found that PeptiCRAd monotherapy could increase the number of antigen spe- cific CD8+ T cells compared to other treatments. However, only the combination with PD-L1 blockade could significantly increase the ra- tio between activated and exhausted pentamer positive cells (p= 0.0058), suggesting that by disrupting the PD-1/PD-L1 axis we could decrease the amount of dysfunctional antigen specific T cells. We ob- served that the anatomical location deeply influenced the state of CD4+ and CD8+ T lymphocytes. In fact, TIM-3 expression was in- creased by 2 fold on TILs compared to splenic and lymphoid T cells. In the CD8+ compartment, the expression of PD-1 on the surface seemed to be restricted to the tumor micro-environment, while CD4 + T cells had a high expression of PD-1 also in lymphoid organs. Interestingly, we found that the levels of PD-1 were significantly higher on CD8+ T cells than on CD4+ T cells into the tumor micro- environment (p < 0.0001).
Conclusions
In conclusion, we demonstrated that the efficacy of immune check- point inhibitors might be strongly enhanced by their combination with cancer vaccines. PeptiCRAd was able to increase the number of antigen-specific T cells and PD-L1 blockade prevented their exhaus- tion, resulting in long-lasting immunological memory and increased median survival
Frank H. Knight and the Committee on Social Thought: Contrasting Visions of Interdisciplinarity in the 1950s
- …